|
|
|
|
| LEADER |
04927nmm a2200301 u 4500 |
| 001 |
EB000677645 |
| 003 |
EBX01000000000000000530727 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642859953
|
| 100 |
1 |
|
|a Speck, Ulrich
|e [editor]
|
| 245 |
0 |
0 |
|a Contrast Media
|h Elektronische Ressource
|c edited by Ulrich Speck
|
| 250 |
|
|
|a 1st ed. 1999
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1999, 1999
|
| 300 |
|
|
|a 139 p
|b online resource
|
| 505 |
0 |
|
|a Contrast media in diagnostic imaging -- General principles of X-ray contrast media -- Structure and properties of X-ray contrast media -- Barium sulfate -- Water-soluble contrast media -- Physicochemical properties of water-soluble contrast media -- Water solubility -- Viscosity/Temperature -- Osmolality -- Hydrophilia/Lipophilia -- Electrical charge -- Others -- Possible uses of X-ray contrast media -- Principles of opacification -- Pharmaceutical product quality -- Practical information at a glance -- Purity of the active ingredient, by- and degradation products -- Formulations -- Additives -- Microbiological quality of the finished product -- Preservation of product quality in hospitals and practices -- Interactions -- Influence on laboratory tests -- Interactions with medicines -- Interaction of contrast media with additives and during interventional procedures -- Effects on blood coagulation -- Risks of contrast media use -- Ionic contrast media -- Nonionic contrast media --
|
| 505 |
0 |
|
|a Delayed reactions -- Causes of contrast media reactions -- General reactions (anaphylactoid reactions) -- Prophylaxis of general reactions -- Dose-dependent side effects -- Prophylaxis and therapy of severe iodine-induced hyperthyroidism -- Renal damage -- Pregnant patients -- Breast-feeding mothers -- Pheochromocytoma -- Sickle-cell anemia -- Drugs and measures for the treatment of a contrast medium reaction -- Special characteristics of the contrast media for magnetic resonance imaging -- Mechanisms of action -- Structure and pharmacological characteristics -- Pharmaceutical product quality -- Administration -- Contrast media for the gastrointestinal tract -- Contrast media for other body cavities -- Special handling characteristics -- Influence on laboratory tests -- Interaction with medications -- Risks related to Magnevist use -- Comparisonwith X-ray contrast media -- Special characteristics of the contrast media for ultrasound -- Contrast media and their mechanisms of action --
|
| 505 |
0 |
|
|a Composition and preparation before use -- Application -- Pharmaceutical product quality -- Influence on laboratory tests -- Interaction with medications -- Risks related to the use of echo contrast media -- Further development of contrast media -- References -- Commercial brands and their iodine content (g)
|
| 653 |
|
|
|a Radiology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Urology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 028 |
5 |
0 |
|a 10.1007/978-3-642-85995-3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-85995-3?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.0757
|
| 520 |
|
|
|a Contrast media in diagnostic imaging 8 Visualization of functions 8 • Morphology 9 • General principles of X-ray contrast media 10 13 Structure and properties of X-ray contrast media Barium sulfate 13 Water-soluble contrast media 14 Chemical structure, biological behavior and use 14 • Conventional, highly hypertonic contrast media 15 • Low-osmolar contrast media, especially non ionic substances 15 • Nonionic contrast media 16 Osmolality and side effects caused by hypertonicity 18 Ionic contrast media 20 21 Contrast media for intravenous cholegraphy • Contrast media for oral cholegraphy 22 • Cations 23 • Synthesis of water-soluble contrast media 25 • Physicochemical properties of water-soluble contrast media 26 26 Water solubility ViscositylTemperature 26 27 Osmolality Hydrophilia/Lipophilia 28 Electrical charge 29 29 Others Possible uses of X-ray contrast media 31 Principles of opacification 31 Pharmaceutical product quality 37 37 Practical information at a glance Purity of the active ingredient, by-and degradation products 38 Formulations 40 5 Additives 40 Microbiological quality of the finished product 42 • Production under controlled environmental conditions 42 • Production process 44 • Sterile filtration, ultrafiltration and sterilization 46 • Sterility test 47 • Test for pyrogens 47 Preservation of product quality in hospitals and practices 48 • Stability in long-term storage and at different temperatures 49 • Sensitivity to irradiation and light; white glass, brown glass, UV-protective foil 50 • Tests for contamination with particles 52 • Risks of microbial contamination 54 • Transferring the contrast medium to sterile containers, disposable syringes, automatic injectors 55
|